A detailed history of Smith, Salley & Associates transactions in Select Sector Spdr Fund Health stock. As of the latest transaction made, Smith, Salley & Associates holds 9,209 shares of XLV stock, worth $1.41 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
9,209
Previous 8,366 10.08%
Holding current value
$1.41 Million
Previous $1.24 Million 8.66%
% of portfolio
0.1%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$138.43 - $147.09 $116,696 - $123,996
843 Added 10.08%
9,209 $1.34 Million
Q1 2024

May 02, 2024

BUY
$138.48 - $147.86 $64,808 - $69,198
468 Added 5.93%
8,366 $1.24 Million
Q3 2023

Oct 27, 2023

SELL
$128.74 - $136.24 $9,784 - $10,354
-76 Reduced 0.95%
7,898 $1.02 Million
Q2 2023

Aug 04, 2023

SELL
$126.74 - $135.66 $51,456 - $55,077
-406 Reduced 4.84%
7,974 $1.06 Million
Q1 2023

May 03, 2023

SELL
$124.15 - $135.82 $1,613 - $1,765
-13 Reduced 0.15%
8,380 $1.08 Million
Q4 2022

Feb 03, 2023

SELL
$121.85 - $140.1 $71,038 - $81,678
-583 Reduced 6.5%
8,393 $1.14 Million
Q3 2022

Nov 01, 2022

SELL
$121.11 - $134.29 $40,935 - $45,390
-338 Reduced 3.63%
8,976 $1.09 Million
Q2 2022

Aug 01, 2022

BUY
$119.89 - $142.83 $35,367 - $42,134
295 Added 3.27%
9,314 $1.19 Million
Q1 2022

May 10, 2022

SELL
$126.55 - $139.44 $46,570 - $51,313
-368 Reduced 3.92%
9,019 $1.24 Million
Q4 2021

Feb 10, 2022

SELL
$125.34 - $141.49 $24,566 - $27,732
-196 Reduced 2.05%
9,387 $1.32 Million
Q3 2021

Nov 05, 2021

SELL
$127.07 - $136.85 $79,291 - $85,394
-624 Reduced 6.11%
9,583 $1.22 Million
Q1 2021

Apr 30, 2021

SELL
$110.8 - $118.5 $74,568 - $79,750
-673 Reduced 6.19%
10,207 $1.19 Million
Q4 2020

Jan 28, 2021

BUY
$101.66 - $113.44 $95,967 - $107,087
944 Added 9.5%
10,880 $1.23 Million
Q3 2020

Nov 05, 2020

SELL
$100.71 - $109.44 $2,618 - $2,845
-26 Reduced 0.26%
9,936 $1.05 Million
Q2 2020

Aug 04, 2020

SELL
$85.21 - $103.92 $94,412 - $115,143
-1,108 Reduced 10.01%
9,962 $997,000
Q1 2020

Apr 24, 2020

BUY
$74.62 - $104.73 $4,551 - $6,388
61 Added 0.55%
11,070 $981,000
Q4 2019

Jan 27, 2020

BUY
$87.95 - $103.11 $67,281 - $78,879
765 Added 7.47%
11,009 $1.12 Million
Q3 2019

Oct 30, 2019

SELL
$89.33 - $92.0 $13,310 - $13,708
-149 Reduced 1.43%
10,244 $923,000
Q2 2019

Jul 12, 2019

SELL
N/A
-438 Reduced 4.04%
10,393 $963,000
Q1 2019

May 03, 2019

SELL
N/A
-207 Reduced 1.88%
10,831 $994,000
Q4 2018

Feb 05, 2019

SELL
N/A
-92 Reduced 0.83%
11,038 $955,000
Q3 2018

Nov 06, 2018

SELL
N/A
-160 Reduced 1.42%
11,130 $1.06 Million
Q2 2018

Aug 10, 2018

SELL
N/A
-2,349 Reduced 17.22%
11,290 $942,000
Q1 2018

May 09, 2018

SELL
N/A
-452 Reduced 3.21%
13,639 $1.11 Million
Q4 2017

Feb 12, 2018

SELL
N/A
-9,224 Reduced 39.56%
14,091 $1.17 Million
Q3 2017

Nov 02, 2017

BUY
N/A
23,315
23,315 $1.91 Million

Others Institutions Holding XLV

About SELECT SECTOR SPDR FUND-HEALTH


  • Ticker XLV
  • Sector ETFs
  • Industry ETFs
More about XLV
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.